Skip to content

Therapeutic Potential of Myofascial Structural Integration in Children With Cerebral Palsy

Therapeutic Potential of Myofascial Structural Integration in Children With Cerebral Palsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01815814
Enrollment
38
Registered
2013-03-21
Start date
2011-11-30
Completion date
2014-11-30
Last updated
2015-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spastic Cerebral Palsy

Keywords

spasticity, cerebral palsy, hemiplegia, hemiparesis, diplegia, paraplegia, quadriplegia, quadriparesis

Brief summary

The investigators hypothesize that children with spastic cerebral palsy will show greater improvements in gross motor function, associated developmental skills and growth after the 3 months of myofascial structural integration treatment, a form of deep massage, than they showed after a 3- or 6-month pre-treatment waiting period. The investigators further hypothesize that children with spastic CP will maintain their gains in gross motor function for ≥ 3 months after completion of MSI treatment.

Detailed description

* The investigators will talk to you by telephone to determine if your child is eligible for the study. * The study lasts for a total of 12 months with the massage treatment period lasting 12 weeks. * The study entails a total of 10 sessions of Myofascial Structural Integration therapy over the 12-week period. Each session will last one hour. * The child will have an evaluation of motor functions and development on enrollment and at three-month intervals for a total of 5 evaluations.

Interventions

OTHERRolfing / Myofascial Structural Integration

Rolfing is similar to deep massage. It is also known as myofascial structural integration.

Sponsors

The Gerber Foundation
CollaboratorOTHER
Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Years to 3 Years
Healthy volunteers
No

Inclusion criteria

* Children from 1 up to, but not including, 7 years of age * Children having the diagnosis of spastic cerebral palsy * Children who have spasticity in one or both upper or lower limbs * Children who are classified as either Gross Motor Function Classification System (GMFCS) level 2, 3 or 4 or Manual Ability Classification System (MACS) level 2, 3, 4 or 5

Exclusion criteria

* Children with active seizure disorders * Children taking more than one medication to control their seizures * Children with severe health problems that could be exacerbated by the treatment (such as severe chronic lung disease) * Children who have undergone surgical treatments or botulinum injections within 6 months of entering the study * Children who have planned surgical interventions during the studies time course * Children with sensory, cognitive or language deficits which would affect their ability to understand directions necessary for assessment.

Design outcomes

Primary

MeasureTime frame
Change in Gross Motor Function Measure Scoreat Enrollment and every 3 months thereafter for up to 12 months

Secondary

MeasureTime frame
Change in GAITRite Mat Measuresat Enrollment and every 3 months thereafter for up to 12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026